Glutamic acid derivatives and pharmaceutical compositions for the treatment of central nervous system disorders
申请人:LILLY S.A.
公开号:EP0867430A2
公开(公告)日:1998-09-30
A pharmaceutical compound of the formula:
in which n is 1 or 2, R1 is -CO2H,
R2 is hydrogen or C1-4 alkyl and
R3 is hydrogen, C1-10 alkyl, C2-10 alkenyl, optionally substituted phenyl, optionally substituted phenyl-C1-4 alkyl, optionally substituted phenyl C2-10 alkenyl, (optionally substituted phenyl)2-C1-4 alkyl, optionally substituted C3-7 cycloalkyl, optionally substituted C3-7 cycloalkyl-C1-4 alkyl or optionally substituted C3-7 cycloalkyl-C2-10 alkenyl, or
R2 and R3, together with the carbon atom to which they are attached, form an optionally substituted c4-7 cycloalkyl group;
or a salt or ester thereof other than the compounds γ-propylidene -L- glutamic acid, γ-ethylidene-L-glutamic acid and γ-methylidene -L- glutamic acid.
一种药物化合物的化学式:其中n为1或2,R1为-CO2H,R2为氢或C1-4烷基,R3为氢、C1-10烷基、C2-10烯基、可选择取代的苯基、可选择取代的苯基-C1-4烷基、可选择取代的苯基C2-10烯基、(可选择取代的苯基)2-C1-4烷基、可选择取代的C3-7环烷基、可选择取代的C3-7环烷基-C1-4烷基或可选择取代的C3-7环烷基-C2-10烯基,或R2和R3与它们所连接的碳原子一起形成一个可选择取代的C4-7环烷基;或其盐或酯,但不包括γ-丙基亚基-L-谷氨酸、γ-乙基亚基-L-谷氨酸和γ-甲基亚基-L-谷氨酸化合物。